{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:09:12Z","timestamp":1791914952661,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015311","name":"Novartis Institutes for BioMedical Research","doi-asserted-by":"publisher","award":["WO2019038717"],"award-info":[{"award-number":["WO2019038717"]}],"id":[{"id":"10.13039\/100015311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015311","name":"Novartis Institutes for BioMedical Research","doi-asserted-by":"publisher","award":["WO2020128972"],"award-info":[{"award-number":["WO2020128972"]}],"id":[{"id":"10.13039\/100015311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","award":["DE-AC02-05CH11231"],"award-info":[{"award-number":["DE-AC02-05CH11231"]}],"id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.chembiol.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T10:39:50Z","timestamp":1677667190000},"page":"235-247.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":166,"title":["Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy"],"prefix":"10.1016","volume":"30","author":[{"given":"Simone","family":"Bonazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"d\u2019Hennezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan E.J.","family":"Beckwith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleem","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Magracheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artiom","family":"Cernijenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Antonakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-eun C.","family":"Bhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana Garc\u00eda","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Wartchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ry R.","family":"Forseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany Hughes","family":"Fortnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Csibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tullai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Carbonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel M.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Larrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Chie-Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Hainzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Kinyamu-Akunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Sabatos-Peyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Dales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric J.","family":"Z\u00e9cri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Shulok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Karen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Briner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery A.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Tallarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Dranoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Bradner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4588-2751","authenticated-orcid":false,"given":"Jonathan M.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2023.02.005_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2023.02.005_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2023.02.005_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","article-title":"Regulatory T\u00a0cells in cancer immunotherapy","volume":"27","author":"Nishikawa","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib5","doi-asserted-by":"crossref","unstructured":"Sakaguchi, S., Mikami, N., Wing, J.B., Tanaka, A., Ichiyama, K., and Ohkura, N. (2020). Annual Review of Immunology Regulatory T Cells and Human Disease. https:\/\/doi.org\/10.1146\/annurev-immunol-042718.","DOI":"10.1146\/annurev-immunol-042718-041717"},{"key":"10.1016\/j.chembiol.2023.02.005_bib6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.molimm.2011.03.006","article-title":"The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity","volume":"48","author":"John","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/imr.12936","article-title":"Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function","volume":"300","author":"Read","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.chembiol.2023.02.005_bib8","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.4049\/jimmunol.0901407","article-title":"Helios deficiency has minimal impact on T\u00a0cell development and function","volume":"183","author":"Cai","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib9","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3\u00a0+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1126\/science.aad0616","article-title":"Stable inhibitory activity of regulatory T\u00a0cells requires the transcription factor Helios","volume":"350","author":"Kim","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.02.005_bib11","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1073\/pnas.1604765113","article-title":"Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity","volume":"113","author":"Nakagawa","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.02.005_bib12","doi-asserted-by":"crossref","first-page":"E2776","DOI":"10.1073\/pnas.1620498114","article-title":"Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T\u00a0cells","volume":"114","author":"Mognol","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.02.005_bib13","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cell.2016.08.052","article-title":"A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T\u00a0cells","volume":"166","author":"Singer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2023.02.005_bib14","doi-asserted-by":"crossref","unstructured":"Hetem\u00e4ki, I., Kaustio, M., Kinnunen, M., Heikkil\u00e4, N., Keskitalo, S., Nowlan, K., Miettinen, S., Sarkkinen, J., Glumoff, V., Andersson, N., et\u00a0al. (2021). Loss-of-function Mutation in IKZF2 Leads to Immunodeficiency with Dysregulated Germinal Center Reactions and Reduction of MAIT Cells.","DOI":"10.1101\/2021.08.25.21262015"},{"key":"10.1016\/j.chembiol.2023.02.005_bib15","doi-asserted-by":"crossref","unstructured":"Shahin, T., Mayr, D., Gawriyski, L., Kostel Bal, S., Zoghi, S., Jimenez-Heredia Ludwig, R., Boutboul, D., Rezaei, N., and Rosenzweig, S. (2022). Identification of Germline Monoallelic Mutations in IKZF2 in Patients with Immune Dysregulation. https:\/\/doi.org\/10.1182\/bloodadvances.2021006367.","DOI":"10.1182\/bloodadvances.2021006367"},{"key":"10.1016\/j.chembiol.2023.02.005_bib16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the \u201cundruggable\u201d cancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2023.02.005_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.02.005_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.02.005_bib19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.02.005_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2023.02.005_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.2874","article-title":"Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs","volume":"21","author":"Chamberlain","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4 CRBN ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2023.02.005_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS","volume":"523","author":"Kr\u00f6nke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2023.02.005_bib24","doi-asserted-by":"crossref","first-page":"eaat0572","DOI":"10.1126\/science.aat0572","article-title":"Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN","volume":"362","author":"Sievers","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.02.005_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A novel cereblon modulator recruits GSPT1 to the CRL4 CRBN ubiquitin ligase","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2023.02.005_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/2643-3230.BCD-20-0105","article-title":"Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies","volume":"2","author":"Renneville","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.chembiol.2023.02.005_bib27","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/acschembio.0c00674","article-title":"Cereblon modulators target ZBTB16 and its oncogenic fusion partners for degradation via distinct structural degrons","volume":"15","author":"Matyskiela","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib28","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/acsmedchemlett.9b00425","article-title":"Evolution of cereblon-mediated protein degradation as a therapeutic modality","volume":"10","author":"Chamberlain","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2023.02.005_bib29","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood-2013-05-484782","volume":"122","author":"Lacy","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2023.02.005_bib30","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1172\/JCI98164","article-title":"Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency","volume":"128","author":"Boutboul","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chembiol.2023.02.005_bib31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/bloodadvances.2017010348","article-title":"IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation","volume":"2","author":"Li","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.chembiol.2023.02.005_bib32","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/hmg\/11.23.2979","article-title":"Okihiro syndrome is caused by SALL4 mutations","volume":"11","author":"Kohlhase","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2023.02.005_bib33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","article-title":"SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate","volume":"14","author":"Matyskiela","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib34","doi-asserted-by":"crossref","first-page":"e38430","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2023.02.005_bib35","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1002\/j.1460-2075.1995.tb00078.x","article-title":"Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3","volume":"14","author":"Zhouravleva","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2023.02.005_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41589-021-00802-w","article-title":"Acute pharmacological degradation of Helios destabilizes regulatory T\u00a0cells","volume":"17","author":"Wang","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/prot.25744","article-title":"Prediction of quaternary structure by analysis of hot spot residues in protein-protein interfaces: the case of anthranilate phosphoribosyltransferases","volume":"87","author":"Schlee","year":"2019","journal-title":"Proteins"},{"key":"10.1016\/j.chembiol.2023.02.005_bib38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4049\/jimmunol.1200792","article-title":"Helios induces epigenetic silencing of Il2 gene expression in regulatory T\u00a0cells","volume":"190","author":"Baine","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1126\/science.add7574","article-title":"Molecular glue CELMoD compounds are regulators of cereblon conformation","volume":"378","author":"Watson","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.02.005_bib40","doi-asserted-by":"crossref","first-page":"102300","DOI":"10.1016\/j.jaut.2019.06.011","article-title":"Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity","volume":"105","author":"Gokhale","year":"2019","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.chembiol.2023.02.005_bib41","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1126\/science.1176077","article-title":"Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T\u00a0cells","volume":"325","author":"Pan","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.02.005_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","article-title":"Molecular and transcriptional basis of CD4+ T\u00a0cell dysfunction during chronic infection","volume":"40","author":"Crawford","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.chembiol.2023.02.005_bib43","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1+ regulatory T\u00a0cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.02.005_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/154065803772613453","article-title":"Homogeneous assays for cellular protein degradation using beta-galactosidase complementation: NF-kappaB\/IkappaB pathway signaling","volume":"1","author":"Zhao","year":"2003","journal-title":"Assay\u00a0Drug Dev. Technol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/adt.2006.052","article-title":"Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery","volume":"5","author":"Olson","year":"2007","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib46","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/jm500305p","article-title":"Structure-based drug design of RN486, a potent and selective Bruton\u2019s tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritis","volume":"58","author":"Lou","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.02.005_bib48","doi-asserted-by":"crossref","first-page":"11683","DOI":"10.3390\/molecules181011683","article-title":"Characterization of amide bond conformers for a novel heterocyclic template of N-acylhydrazone derivatives","volume":"18","author":"Lopes","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.chembiol.2023.02.005_bib49","doi-asserted-by":"crossref","first-page":"102074","DOI":"10.1016\/j.cbpa.2021.07.001","article-title":"Recent advancements in mass spectrometry-based tools to investigate newly synthesized proteins","volume":"66","author":"van Bergen","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib50","doi-asserted-by":"crossref","first-page":"e62210","DOI":"10.7554\/eLife.62210","article-title":"Proteomic analysis of young and old mouse hematopoietic stem cells and their progenitors reveals post-transcriptional regulation in stem cells","volume":"9","author":"Zaro","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2023.02.005_bib51","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2023.02.005_bib52","unstructured":"Arista, L., Broennimann, V., D\u2019Alessandro, P.L., Doumampouom-metoul, L., Goude, M.-L., Hebach, C., Hollingsworth, G.J., Juelin, I.K.J., Kirman, L.C., Lorber, J., et\u00a0al. (2021). Bifunctional Degraders and Their Methods of Use. 1\u2013513."},{"key":"10.1016\/j.chembiol.2023.02.005_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acschembio.7b00549","article-title":"CRISPR-mediated tagging of endogenous proteins with a luminescent peptide","volume":"13","author":"Schwinn","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib54","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1002\/jps.20913","article-title":"Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery","volume":"96","author":"Zhou","year":"2007","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.chembiol.2023.02.005_bib55","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.xphs.2021.01.029","article-title":"Predicting oral absorption for compounds outside the rule of five property space","volume":"110","author":"Huth","year":"2021","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.chembiol.2023.02.005_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4939-2272-7_12","article-title":"Site-specific biotinylation of purified proteins using BirA","volume":"1266","author":"Fairhead","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.chembiol.2023.02.005_bib58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.chembiol.2023.02.005_bib59","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.chembiol.2023.02.005_bib60","doi-asserted-by":"crossref","unstructured":"Dunsford, L.S., Thoirs, R.H., Rathbone, E., and Patakas, A. (2020). A human in\u00a0vitro T\u00a0cell exhaustion model for assessing immuno-oncology therapies. pp. 89\u2013101. https:\/\/doi.org\/10.1007\/978-1-0716-0171-6_6.","DOI":"10.1007\/978-1-0716-0171-6_6"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945623000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945623000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:43:04Z","timestamp":1762526584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945623000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2451945623000545"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2023.02.005","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}